Study: Questions raised on profit-backed clinical trials

05/16/2006 | United Press International

A study in today's issue of the Journal of the American Medical Association found 67% of cardiovascular clinical trials backed by for-profit groups favored newer treatments while only 49% did so among nonprofit-backed trials. While it adds fuel to the argument that the objectivity of researchers is affected by financial ties to drug companies, the authors say there may be other explanations for the results.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA